Regulatory intelligence

The only peptide platform that scans regulators every morning.

We watch what the FDA, DEA, FTC, USP, and every state medical and pharmacy board publish. If something touches peptides or compounding or telemedicine, we tell you before you see it in the news.

What we watch

Four federal regulators. Fifty state boards. One quiet inbox.

The FDA writes the compounding rules. The DEA sets the controlled substance schedule. The FTC handles marketing enforcement. The USP writes the compounding chapters. Then every state has its own medical board and its own pharmacy board, and either one can discipline a prescriber. That is more than 100 sources. We check them so you do not have to.

Coverage

The monitoring register: 10 planned jobs

Two jobs run daily today: the federal scan that covers the FDA, DEA, FTC, and USP, and the PubMed literature scan. The 50 state boards plus DC roll out weekly. Here is what each job watches and what makes it speak up.

Regulator or scopeCadenceWhat it watchesThresholdStatus
Federal regulatory scanDaily, 7am ETFDA 503A and 503B compounding lists, PCAC dockets, DEA scheduling and the Federal Register, FTC marketing enforcement, and USP compounding chaptersAny peptide, compounding, or telemedicine changeRunning daily today
PubMed peptide and biomarker literature scanDaily, 7am ETNew peptide and biomarker studies as PubMed indexes themA study that changes a peptide's use, dose, or cautionRunning daily today
State boards: Texas and CaliforniaWeeklyTexas Medical Board, Texas Pharmacy, Medical Board of California, and California PharmacyPeptide, telemedicine, or compounding action onlyWeekly rollout planned
State boards: Northeast, 11 statesWeeklyMedical and pharmacy board news for CT, DE, ME, MD, MA, NH, NJ, NY, PA, RI, and VTPeptide, telemedicine, or compounding action onlyWeekly rollout planned
State boards: Southeast, 12 statesWeeklyMedical and pharmacy board news for AL, AR, FL, GA, KY, LA, MS, NC, SC, TN, VA, and WVPeptide, telemedicine, or compounding action onlyWeekly rollout planned
State boards: Midwest, 12 statesWeeklyMedical and pharmacy board news for IL, IN, IA, KS, MI, MN, MO, NE, ND, OH, SD, and WIPeptide, telemedicine, or compounding action onlyWeekly rollout planned
State boards: West plus DC, 13 states and DCWeeklyMedical and pharmacy board news for AK, AZ, CO, HI, ID, MT, NV, NM, OK, OR, UT, WA, WY, and DCPeptide, telemedicine, or compounding action onlyWeekly rollout planned
Why this is different

Built to be quiet until it matters.

Not just alerts. A daily one page PDF to Drive.

Every morning at 7am ET a short PDF lands in your shared Drive folder. If nothing changed, the PDF says so and still lists everything we checked. You get a full record either way.

Threshold discipline.

We do not send noise. Routine state board discipline that has nothing to do with peptides does not trigger anything. The scan only flags peptide, compounding, and telemedicine signal.

Linked to your prescribing framework.

When a new study or ruling changes what a peptide should be prescribed for, or at what dose, or with what caution, we write a plain English delta note so you can update your protocol. This is the Sequence Method feedback loop.

The daily PDF

What the daily PDF looks like

Coming online tomorrow. The first scan fires Wednesday, July 8 at 7am Eastern. We will link a real sample here once the first three days have run.

Ready to see a live scan?

We only take a limited number of prescribers per quarter. Apply for early access.

Regulatory intelligence for peptide prescribers | Scriptura Health | Scriptura Health